Canada Veterinary Ocular Medicine Size, Medication Type (2024-2032)

Free

in USD Million

.js-only{display:none !important;}

Chart preview (first 9 rows), unit: in USD Million.

Canada Veterinary Ocular Medicine Size, Medication Type (2024-2032) chart preview

Canada Veterinary Ocular Medicine Size, Medication Type (2024-2032) chart data
Year	Antibiotics	NSAIDs (Non Steroidal Anti Inflammatory Drugs)	Corticosteroids	Antivirals (Eye Drops, Oral)	Others
2024	11760.02	4130.03	4549.06	1211.88	8495.19
2025	11855.44	4175.75	4661.1	1247.04	8795.68
2026	11969.85	4228.41	4783.19	1285.18	9116.48
2027	12114.11	4291.92	4920.14	1327.63	9467.28
2028	12304.31	4372.09	5079.27	1376.43	9862.85
2029	12559.54	4475.87	5269.57	1434.11	10321.76
2030	12903.89	4612.07	5502.75	1503.98	10868.4
2031	13367.98	4791.96	5794.05	1590.37	11534.86
2032	13990.88	5029.96	6163.38	1698.99	12363.33

Technological Advancements to Enhance Clinical Precision in the Canada Veterinary Ocular Medicine Market (2024–2032)

Published by MMR Statistics Reserch Team, November 2025

The Canada Veterinary Ocular Medicine Market demonstrated consistent growth from 2024 onward, with antibiotics leading the segment throughout the base year. In 2024, antibiotics recorded the highest market value at USD 11,760.02 thousand, followed by corticosteroids at USD 4,549.06 thousand and NSAIDs at USD 4,130.03 thousand, highlighting the market’s reliance on antibacterial and anti-inflammatory therapies. Antivirals, valued at USD 1,211.88 thousand, represented the smallest share, emphasising their specialised use in managing ocular infections.

In 2025, the Canada Veterinary Ocular Medicine market is estimated to maintain steady progression, supported by clinical adoption and broader distribution of ocular care solutions. By 2032, the Canada Veterinary Ocular Medicine market is projected to remain dominated by antibiotics, reaching USD 13,990.88 thousand, while antivirals are expected to grow to USD 1,698.99 thousand, maintaining their targeted yet limited presence. Steady expansion is driven by technology-driven innovations, increased accessibility to advanced treatments, and rising awareness of animal ocular health, ensuring greater precision in veterinary ophthalmic care across diverse animal segments.

More statistics on Veterinary Ocular Medicine

Related reports

Recommended and recent reports

Subscriptions

Stay ahead of Veterinary Ocular Medicine with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Veterinary Ocular Medicine?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst

Canada Veterinary Ocular Medicine Size, Medication Type (2024-2032)

in USD Million

Technological Advancements to Enhance Clinical Precision in the Canada Veterinary Ocular Medicine Market (2024–2032)

OTHER STATISTICS ON TOPIC

More statistics on Veterinary Ocular Medicine

Technological Advancements to Enhance Clinical Precision in the Canada Veterinary Ocular Medicine Market (2024–2032)

OTHER STATISTICS ON TOPIC

More statistics on Veterinary Ocular Medicine

Download

Download

Recommended and recent reports

Stay ahead of Veterinary Ocular Medicine with tailored access

Need a bespoke deep-dive on Veterinary Ocular Medicine?